Honey bee as apitoxin, carries several active components, the most abundant of which is melittin, and the most biologically active are enzymes, particularly phospholipase A2. Bee venom is under laboratory and clinical research for its potential properties and uses in reducing risks for adverse events from bee venom therapy, rheumatoid arthritis, and use as an immunotherapy for protection against allergies from insect stings. Bee venom products are marketed in many countries, but, as of 2018, there are no approved clinical uses for these products which carry various warnings for potential allergic reactions. With an increased number of honey bees in a specific
Hennessey Venom GT the car's six year production run and to mark an end to the production of the Venom GT. The engine output is the same but the curb weight has been decreased by . The livery of the car is a "Glacier Blue" paint job with double narrow white stripes. The vehicle was pre-sold for before its public debut. The Hennessey Venom GT is succeeded by the Hennessey Venom F5, which was unveiled in November 2017; unlike its predecessor, it is a series production car built completely from the ground up, including chassis and engine. Hennessey Venom GT The Hennessey Venom